Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Elisabeth G Celius, Heidi Thompson, Maija Pontaga, Dawn Langdon, Alice Laroni, Stanca Potra, Trishna Bharadia, David Yeandle, Jane Shanahan, Pieter van Galen, Nektaria Alexandri & Jürg Kesselring. (2021) Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives. Patient Preference and Adherence 15, pages 15-27.
Read now
Read now
Claude Mékiès, Olivier Heinzlef, Béatrice Jenny, Anne-Laure Ramelli & Pierre Clavelou. (2018) Treatment satisfaction and quality of life in patients treated with fingolimod. Patient Preference and Adherence 12, pages 899-907.
Read now
Read now
Articles from other publishers (55)
B. Bourre, O. Casez, J. Ciron, A. Gueguen, A. Kwiatkowski, X. Moisset, A. Montcuquet & X. Ayrignac. (2023) Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice. Revue Neurologique 179:4, pages 256-264.
Crossref
Crossref
Monika Christ, Katrin Schuh & Antonios Bayas. (2023) Large-scale cross-sectional online survey on patient-neurologist communication, burden of disease assessment and disease monitoring in people with multiple sclerosis. Frontiers in Neurology 13.
Crossref
Crossref
Charee M. Thompson, Manuel D. Pulido, Sara Babu, Nicole Zenzola & Chungyi Chiu. (2022) Communication between persons with multiple sclerosis and their health care providers: A scoping review. Patient Education and Counseling 105:12, pages 3341-3368.
Crossref
Crossref
Jeri Burtchell, Daisy Clemmons, Joann Clemmons, Tim Sabutis, Adeline Rosenberg, Jennifer Graves, Michael L. Sweeney, John Kramer, Marina Ziehn, Brandon Brown, Jamie L. Weiss & Ahmed Z. Obeidat. (2022) A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies. Neurology and Therapy 11:3, pages 955-979.
Crossref
Crossref
D.A. García Estévez, L. Cid Conde & A. Juanatey García. (2022) Analysis of medication persistence and reasons for discontinuation of treatment with teriflunomide and dimethyl fumarate in a hospital series of patients with multiple sclerosis. Neurology Perspectives 2:3, pages 168-170.
Crossref
Crossref
Ricardo Nicolás Alonso, Aníbal Chertcoff, María Bárbara Eizaguirre, Johana Bauer, Felisa Leguizamón, María Celeste Curbello, Fátima Pagani Cassará, Orlando Garcea, Adriana Carrá, Alejandra Palma & Berenice Anabel Silva. (2022) Decision making process in multiple sclerosis: An Argentine pilot study. Multiple Sclerosis and Related Disorders 61, pages 103751.
Crossref
Crossref
Massimiliano Mirabella, Pietro Annovazzi, Wallace Brownlee, Jeffrey A. Cohen, Christoph Kleinschnitz & Christian Wolf. (2022) Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?. Frontiers in Neurology 13.
Crossref
Crossref
Jürg Kesselring, Alexey Boyko, Alice Laroni, Trishna Bharadia, Pieter van Galen & Nektaria Alexandri. (2021) Caregiver Involvement in MS: Duty or Disruption?. Neurology and Therapy 11:1, pages 9-20.
Crossref
Crossref
Gina Carey, Neil Wilson, Jessie Janssen, Ambreen Chohan, David Rog & Hazel Roddam. (2022) “I'm walking into the unknown”: Qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatment. Multiple Sclerosis and Related Disorders 58, pages 103464.
Crossref
Crossref
A. M. Alhawsawi, К.М. Alsohaimi, M. S. Alwadie & B. A. Alshehri. (2022) Nurse’s Attitude towards Patient’s Rights at Eradah Mental Health Complex in Jeddah City, Saudi Arabia. THE NEW ARMENIAN MEDICAL JOURNAL:3, pages 4-14.
Crossref
Crossref
Maha Wybitul, Harun Njago, Agata Luczkiewicz & Hans Pihan. (2022) Patient Satisfaction in a Multidisciplinary Multiple Sclerosis Care Unit: A Swiss Single-centre Study. US Neurology 18:2, pages 142.
Crossref
Crossref
Hernan Inojosa, Undine Proschmann, Katja Akgün & Tjalf Ziemssen. (2022) The need for a strategic therapeutic approach: multiple sclerosis in check. Therapeutic Advances in Chronic Disease 13, pages 204062232110630.
Crossref
Crossref
Francisco J. Campos-Lucas, Óscar Fernández-Fernández, Diana Monge-Martín, Ester Moral-Torres, Pedro Carrascal-Rueda & Fernando Caballero-Martínez. (2022) The evolution of multiple sclerosis in Spain over the last decade from the patient's perspective. Multiple Sclerosis and Related Disorders 57, pages 103355.
Crossref
Crossref
Anna Sippel, Karin Riemann-Lorenz, Jutta Scheiderbauer, Ingo Kleiter, Rebecca Morrison, Christopher Kofahl & Christoph Heesen. (2021) Patients experiences with multiple sclerosis disease-modifying therapies in daily life – a qualitative interview study. BMC Health Services Research 21:1.
Crossref
Crossref
Eluned Price, Robyn Lucas & Jo Lane. (2021) Experiences of healthcare for people living with multiple sclerosis and their healthcare professionals. Health Expectations 24:6, pages 2047-2056.
Crossref
Crossref
Leorah Freeman, Arianna Kee, Marc Tian & Rina Mehta. (2021) Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy. Drugs - Real World Outcomes 8:4, pages 497-508.
Crossref
Crossref
Radka Bužgová, Radka Kozáková & Michal Bar. (2020) Satisfaction of Patients With Severe Multiple Sclerosis and Their Family Members With Palliative Care: Interventional Study. American Journal of Hospice and Palliative Medicine® 38:11, pages 1348-1355.
Crossref
Crossref
Ester Moral-Torres, Óscar Fernández-Fernández, Fernando Caballero-Martínez, Pedro Carrascal-Rueda, Diana Monge-Martín & Francisco J. Campos-Lucas. (2021) Patient experience and self-perceived biopsychosocial burden of people living with multiple sclerosis: An epidemiological survey (BPS-MuScle study) in Spain. Multiple Sclerosis and Related Disorders 56, pages 103186.
Crossref
Crossref
Pablo A. López, Ricardo Alonso, Berenice Silva & Edgar Carnero Contentti. (2021) Natalizumab subcutaneous injection for the treatment of relapsing multiple sclerosis patients: A new delivery route. Multiple Sclerosis and Related Disorders 55, pages 103179.
Crossref
Crossref
Royce W. WaltripIIII, Nancy Mahler, Alina Ahsan & Leslie B. Herbert. (2021) Effect of Health Care Providers’ Focused Discussion and Proactive Education About Relapse Management on Patient Reporting of Multiple Sclerosis Relapse. International Journal of MS Care 23:4, pages 151-156.
Crossref
Crossref
Maria Scholz, Rocco Haase, Katrin Trentzsch, Heidi Stölzer-Hutsch & Tjalf Ziemssen. (2021) Improving Digital Patient Care: Lessons Learned from Patient-Reported and Expert-Reported Experience Measures for the Clinical Practice of Multidimensional Walking Assessment. Brain Sciences 11:6, pages 786.
Crossref
Crossref
Bryan E. Davis, Lynsey Lakin, Cherie C. Binns, Keisha M. Currie & Mary R. Rensel. (2021) Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review. Neurology and Therapy 10:1, pages 99-119.
Crossref
Crossref
Lynsey Lakin, Bryan E. Davis, Cherie C. Binns, Keisha M. Currie & Mary R. Rensel. (2021) Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review. Neurology and Therapy 10:1, pages 75-98.
Crossref
Crossref
Cássia Elisa Marin, Paula Prado Kfouri, Dagoberto Callegaro, Marco Aurélio Lana-Peixoto, Antonio Pereira Gomes Neto, Claudia Cristina Ferreira Vasconcelos, José Artur Costa d'Almeida, Marcus Vinícius Magno Gonçalves, Maria Fernanda Mendes, Mônica Koncke Fiuza Parolin, Osvaldo Nascimento, Paulo Diniz da Gama, Rafael Paternò Castello Dias-Carneiro, Ronaldo Maciel Dias, Alfredo Damasceno, Gustavo San Martin & Jefferson Becker. (2021) Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges. Multiple Sclerosis and Related Disorders 50, pages 102806.
Crossref
Crossref
Augusto A Miravalle, Joshua Katz, Derrick Robertson, Brooke Hayward, Danielle E Harlow, Lori A Lebson, Jacob A Sloane, Ann D Bass & Edward J Fox. (2021) CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis. Neurodegenerative Disease Management 11:2, pages 99-111.
Crossref
Crossref
Anna Jopowicz, Agnieszka Piechal & Iwona Kurkowska-Jastrzębska. (2021) Why do patients not follow therapeutic recommendations?. Pharmacotherapy in Psychiatry and Neurology 37:1, pages 75-93.
Crossref
Crossref
Jan Hillert, Melinda Magyari, Per Soelberg Sørensen, Helmut Butzkueven, Anneke Van Der Welt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Fabio Pellegrini, Robert Hyde, Leszek Stawiarz, Ali Manouchehrinia & Tim Spelman. (2021) Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network. Frontiers in Neurology 12.
Crossref
Crossref
Edgar Carnero Contentti, Susana Giachello & Jorge Correale. (2020) Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients. Multiple Sclerosis Journal 27:1, pages 117-129.
Crossref
Crossref
Owen Doody. 2021. Clinical Nurse Specialist Role and Practice. Clinical Nurse Specialist Role and Practice
111
124
.
Sanni Lahdenperä, Merja Soilu‐Hänninen, Hanna‐Maija Kuusisto, Sari Atula, Jouni Junnila & Anders Berglund. (2020) Medication adherence/persistence among patients with active multiple sclerosis in Finland. Acta Neurologica Scandinavica 142:6, pages 605-612.
Crossref
Crossref
Kottil Rammohan, Patricia K. Coyle, Elke Sylvester, Andrew Galazka, Fernando Dangond, Megan Grosso & Thomas P. Leist. (2020) The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review. Drugs 80:18, pages 1901-1928.
Crossref
Crossref
Anne Christin Rahn, Alessandra Solari, Heleen Beckerman, Richard Nicholas, David Wilkie, Christoph Heesen & Andrea Giordano. (2020) “I Will Respect the Autonomy of My Patient”. International Journal of MS Care 22:6, pages 285-293.
Crossref
Crossref
Christopher P. Denton, Bee Laird, Lizette Moros & Jose Luis Luna Flores. (2020) Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis. Clinical Rheumatology 39:10, pages 2989-2998.
Crossref
Crossref
Carrie M Hersh & Le H Hua. (2020) Comparative effectiveness studies in multiple sclerosis. Neurodegenerative Disease Management.
Crossref
Crossref
Patrick Vermersch, Jane Shanahan, Dawn Langdon, David Yeandle, Nektaria Alexandri & Sven Schippling. (2019) Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis. Neurology and Therapy 9:1, pages 1-10.
Crossref
Crossref
Michelle MEEHAN & Owen DOODY. (2020) The role of the clinical nurse specialist multiple sclerosis, the patients’ and families’ and carers’ perspective: An integrative review. Multiple Sclerosis and Related Disorders 39, pages 101918.
Crossref
Crossref
B. Roukos-Damoury & F. Abou-Mrad. (2020) Ethical dilemmas in Multiple Sclerosis: A comprehensive review. Ethics, Medicine and Public Health 13, pages 100465.
Crossref
Crossref
Kathryn Volpicelli Leonard, Courtney Robertson, Amrita Bhowmick & Leslie Beth Herbert. (2020) Perceived Treatment Satisfaction and Effectiveness Facilitators Among Patients With Chronic Health Conditions: A Self-Reported Survey. Interactive Journal of Medical Research 9:1, pages e13029.
Crossref
Crossref
Celia Oreja-Guevara, Stanca Potra, Birgit Bauer, Diego Centonze, Maria-Paz Giambastiani, Gavin Giovannoni, Jürg Kesselring, Dawn Langdon, Sarah A. Morrow, Jocelyne Nouvet-Gire, Maija Pontaga, Peter Rieckmann, Sven Schippling, Nektaria Alexandri, Jane Shanahan, Heidi Thompson, Pieter Van Galen, Patrick Vermersch & David Yeandle. (2019) Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care. Advances in Therapy 36:11, pages 3238-3252.
Crossref
Crossref
Daniel Ontaneda, Emma Tallantyre, Tomas Kalincik, Sarah M Planchon & Nikos Evangelou. (2019) Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis. The Lancet Neurology 18:10, pages 973-980.
Crossref
Crossref
Emanuele D'Amico, Rocco Haase & Tjalf Ziemssen. (2019) Review: Patient-reported outcomes in multiple sclerosis care. Multiple Sclerosis and Related Disorders 33, pages 61-66.
Crossref
Crossref
Nananda Col, Enrique Alvarez, Vicky Springmann, Carolina Ionete, Idanis Berrios Morales, Andrew Solomon, Christen Kutz, Carolyn Griffin, Brenda Tierman, Terrie Livingston, Michelle Patel, Danny van Leeuwen, Long Ngo & Lori Pbert. (2019) A Novel Tool to Improve Shared Decision Making and Adherence in Multiple Sclerosis: Development and Preliminary Testing. MDM Policy & Practice 4:2, pages 238146831987913.
Crossref
Crossref
Patricia K. Coyle, Bhupendra Khatri, Keith R. Edwards, José E. Meca-Lallana, Steve Cavalier, Pascal Rufi, Myriam Benamor, Elizabeth M. Poole, Miqun Robinson & Ralf Gold. (2019) Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study. Multiple Sclerosis and Related Disorders 31, pages 157-164.
Crossref
Crossref
Sandra L. Neate, Keryn L. Taylor, George A. Jelinek, Alysha M. De Livera, Chelsea R. Brown & Tracey J. Weiland. (2019) Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification. PLOS ONE 14:2, pages e0212422.
Crossref
Crossref
Daniel R. Wynn. (2019) Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use. Multiple Sclerosis International 2019, pages 1-19.
Crossref
Crossref
Hannah Brown, Simone Gabriele & Joanna White. (2018) Physician and patient treatment decision-making in relapsing-remitting multiple sclerosis in Europe and the USA. Neurodegenerative Disease Management 8:6, pages 371-376.
Crossref
Crossref
David Yeandle, Peter Rieckmann, Gavin Giovannoni, Nektaria Alexandri & Dawn Langdon. (2018) Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier. Neurology and Therapy 7:2, pages 179-187.
Crossref
Crossref
Nananda F. Col, Andrew J. Solomon, Vicky Springmann, Carolina Ionete, Enrique Alvarez, Brenda Tierman, Christen Kutz, Idanis Berrios Morales, Carolyn Griffin, Long H. Ngo, David E. Jones, Glenn Phillips, Ashli Hopson & Lori Pbert. (2018) Evaluation of a Novel Preference Assessment Tool for Patients with Multiple Sclerosis. International Journal of MS Care 20:6, pages 260-267.
Crossref
Crossref
Tara A. Nazareth, Andrew R. Rava, Jackie L. Polyakov, Edward N. Banfe, Royce W. Waltrip II, Kristine B. Zerkowski & Leslie B. Herbert. (2018) Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Multiple Sclerosis and Related Disorders 26, pages 219-234.
Crossref
Crossref
Francois Grand′Maison, Michael Yeung, SarahA Morrow, Liesly Lee, Francois Emond, BrianJ Ward, Pierre Laneuville & Robyn Schecter. (2018) Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches. Neural Regeneration Research 13:11, pages 1871.
Crossref
Crossref
Peter Rieckmann, Diego Centonze, Irina Elovaara, Gavin Giovannoni, Eva Havrdová, Jurg Kesselring, Gisela Kobelt, Dawn Langdon, Sarah A Morrow, Celia Oreja-Guevara, Sven Schippling, Christoph Thalheim, Heidi Thompson, Patrick Vermersch, Karen Aston, Birgit Bauer, Christy Demory, Maria Paz Giambastiani, Jana Hlavacova, Jocelyne Nouvet-Gire, George Pepper, Maija Pontaga, Emma Rogan, Chrystal Rogalski, Pieter van Galen & Ali-Frédéric Ben-Amor. (2018) Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Multiple Sclerosis and Related Disorders 19, pages 153-160.
Crossref
Crossref
L Dyck. (2017) Resonance and Dissonance Asymmetry in Effective Physician–Patient Relationships. Journal of the Royal College of Physicians of Edinburgh 47:4, pages 314-323.
Crossref
Crossref
LARA GITTO. 2017. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis
17
37
.
Kjell-Morten Myhr, Mathias Mäurer, Marisa Martínez Ginés, Federica Esposito & Ralf Linker. (2017) Break-out session highlights. Neurodegenerative Disease Management 7:6s, pages 45-49.
Crossref
Crossref
Javier Ballesteros, Ester Moral, Luis Brieva, Elena Ruiz-Beato, Daniel Prefasi & Jorge Maurino. (2017) Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref